News Archive
Grant of Options
On 19 May 2009 the Board of Eden Research plc ("Eden") granted options to the following directors under the terms of its Share Option Scheme:
| Director | Share options granted | Total options held |
| Ken Brooks | 900,000 | 2,878,487 |
| Timothy Griffiths | 900,000 | 2,878,487 |
| Alex Abrey | 450,000 | 550,000 |
| Clive Newitt | 150,000 | 225,000 |
| Stephen O'Brien | 100,000 | 100,000 |
| Sir Ben Gill | 100,000 | 100,000 |
The new options can be exercised at a price of 26 pence per share and have been granted in recognition of the directors' efforts over the past three years to bring Eden towards commercialisation and as a result of the Company's low remuneration policy. The options can be exercised any time up to 19 May 2014.
For further information:
| Tim Griffiths, Chief Executive | Eden Research plc | Tel: 01993 868844 |
| Matthew Robinson | FinnCap | Tel: 020 7600 1658 |
ABOUT EDEN RESEARCH PLC
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene chemistry and other patented environmentally friendly technologies. Eden is currently working alongside universities and partner companies in developing its product portfolio towards commercialisation.
For further information please visit www.edenresearch.com.